SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • 1
    Krausz C,Gervasi G,Forti G,Baldi E. Effect of platelet-activating factor on motility and acrosome reaction of human spermatozoa. Hum Reprod 1994; 9: 471476.
  • 2
    Nasu K,Narahara H,Matsui N,Kawano Y,Tanaka Y,Miyakawa I. Platelet-activating factor stimulates cytokine production by human endometrial stromal cells. Mol Hum Reprod 1999; 5: 548553.
  • 3
    Wu C,Stojanov T,Chami O,Ishii S,Shimizu T,Li A,O'neill C. Evidence for the autocrine induction of capacitation of mammalian spermatozoa. J Biol Chem 2001; 276: 2696226968.
  • 4
    Yang W,Diehl JR,Yerle M,Ford JJ,Christenson RK,Roudebush WE,Plummer WE. Chromosomal location, structure, and temporal expression of the platelet-activating factor receptor (PAFr) gene in porcine endometrium and embryos relative to estrogen receptor alpha gene expression. Mol Reprod Dev 2003; 64: 412.
  • 5
    Abisogun AO,Braquet P,Tsafriri A. The involvement of platelet activating factor in ovulation. Science 1989; 243: 381383.
  • 6
    Li XM,Sagawa N,Ihara Y,Okagaki A,Hasegawa M,Inamori K,Itoh H,Mori T,Ban C. The involvement of platelet-activating factor in thrombocytopenia and follicular rupture during gonadotropin-induced superovulation in immature rats. Endocrinology 1991; 129: 31323138.
  • 7
    Amiel ML,Testart J,Benveniste J. Platelet-activating factor-acether is a component of human follicular fluid. Fertil Steril 1991; 56: 6265.
  • 8
    Alexander BM,Van Kirk EA,Murdoch WJ. Secretion of platelet-activating factor by periovulatory ovine follicles. Life Sci 1990; 47: 865868.
  • 9
    Espey LL,Tanaka N,Woodard DS,Harper MJ,Okamura H. Decrease in ovarian platelet-activating factor during ovulation in the gonadotropin-primed immature rat. Biol Reprod 1989; 41: 104110.
  • 10
    Lacasse C,Turcotte S,Gingras D,Stankova J,Rola-Pleszczynski M. Platelet-activating factor stimulates interleukin-6 production by human endothelial cells and synergizes with tumor necrosis factor for enhanced production of granulocyte-macrophage colony stimulating factor. Inflammation 1997; 21: 145158.
  • 11
    Roth M,Nauck M,Yousefi S,Tamm M,Blaser K,Perruchoud AP,Simon HU. Platelet-activating factor exerts mitogenic activity and stimulates expression of interleukin 6 and interleukin 8 in human lung fibroblasts via binding to its functional receptor. J Exp Med 1996; 184: 191201.
  • 12
    Ahamed J,Ali H. Distinct roles of receptor phosphorylation, G protein usage, and mitogen-activated protein kinase activation on platelet activating factor-induced leukotriene C (4) generation and chemokine production. J Biol Chem 2002; 277: 2268522691.
  • 13
    Syrbu SI,Waterman WH,Molski TF,Nagarkatti D,Hajjar JJ,Sha'afi RI. Phosphorylation of cytosolic phospholipase A2 and the release of arachidonic acid in human neutrophils. J Immunol 1999; 162: 23342340.
  • 14
    Izumi T,Shimizu T. Platelet-activating factor receptor: Gene expression and signal transduction. Biochim Biophys Acta 1995; 1259: 317333.
  • 15
    Ali H,Richardson RM,Tomhave ED,Dubose RA,Haribabu B,Snyderman R. Regulation of stably transfected platelet activating factor receptor in RBL-2H3 cells. Role of multiple G proteins and receptor phosphorylation. J Biol Chem 1994; 269: 2455724563.
  • 16
    Haribabu B,Zhelev DV,Pridgen BC,Richardson RM,Ali H,Snyderman R. Chemoattractant receptors activate distinct pathways for chemotaxis and secretion. Role of G-protein usage. J Biol Chem 1999; 274: 3708737092.
  • 17
    Han WK,Sapirstein A,Hung CC,Alessandrini A,Bonventre JV. Cross-talk between cytosolic phospholipase A2 alpha (cPLA2 alpha) and secretory phospholipase A2 (sPLA2) in hydrogen peroxide-induced arachidonic acid release in murine mesangial cells: sPLA2 regulates cPLA2 alpha activity that is responsible for arachidonic acid release. J Biol Chem 2003; 278: 2415324163.
  • 18
    Behrman HR,Kodaman PH,Preston SL,Gao S. Oxidative stress and the ovary. J Soc Gynecol Investig 2001; 8: S40S42.
  • 19
    Morrow JD,Hill KE,Burk RF,Nammour TM,Badr KF,Roberts LJ. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 1990; 87: 93839387.
  • 20
    Kayganich-Harrison KA,Rose DM,Murphy RC,Morrow JD,Roberts LJ. Collision-induced dissociation of F2-isoprostane-containing phospholipids. J Lipid Res 1993; 34: 12291235.
  • 21
    Banerjee M,Kang KH,Morrow JD,Roberts LJ,Newman JH. Effects of a novel prostaglandin, 8-epi-PGF2 alpha, in rabbit lung in situ. Am J Physiol 1992; 263: H660H663.
  • 22
    Vacchiano CA,Tempel GE. Role of nonenzymatically generated prostanoid, 8-iso-PGF2 alpha, in pulmonary oxygen toxicity. J Appl Physiol 1994; 77: 29122917.
  • 23
    Löhrke B,Viergutz T,Krüger B. Polar phospholipids from bovine endogenously oxidized low density lipoprotein interfere with follicular thecal function. J Mol Endocrinol 2005; 35: 531545.
  • 24
    Krüger B,Albrecht E,Lerch MM. The role of intracellular calcium signaling in premature protease activation and the onset of pancreatitis. Am J Pathol 2000; 157: 4350.
  • 25
    Kaposi AS,Veress G,Vásárhelyi B,Macardle P,Bailey S,Tulassay T,Treszl A. Cytometry-acquired calcium-flux data analysis in activated lymphocytes. Cytometry A 2008; 73: 246253.
  • 26
    Casals-Stenzel J,Heuer HO. Use of WEB 2086 and WEB 2170 as platelet-activating factor antagonists. Methods Enzymol 1990; 187: 455465.
  • 27
    Dupré DJ,Le Gouill C,Rola-Pleszczynski M,Stanková J. Inverse agonist activity of selected ligands of platelet-activating factor receptor. J Pharmacol Exp Ther 2001; 299: 358365.
  • 28
    Mason MJ,Garcia-Rodriguez C,Grinstein S. Coupling between intracellular Ca2+ stores and the Ca2+ permeability of the plasma membrane. Comparison of the effects of thapsigargin, 2,5-di-(tert-butyl)-1,4-hydroquinone, and cyclopiazonic acid in rat thymic lymphocytes. J Biol Chem 1991; 266: 2085620862.
  • 29
    Tiemann U,Neels P,Pöhland R,Walzel H,Löhrke B. Influence of inhibitors on increase in intracellular free calcium and proliferation induced by platelet-activating factor in bovine oviductal cells. J Reprod Fertil 1999; 116: 6372.
  • 30
    Brown SL,Jala VR,Raghuwanshi SK,Nasser MW,Haribabu B,Richardson RM. Activation and regulation of platelet-activating factor receptor: Role of G(i) and G(q) in receptor-mediated chemotactic, cytotoxic, and cross-regulatory signals. J Immunol 2006; 177: 32423249.
  • 31
    Komatsu H,Nagasawa M,Okumoto T. Inhibition of leukocyte adhesion to endothelial cells of human umbilical vein by Y-24180, an antagonist of platelet-activating factor. Int J Immunopharmacol 1993; 15: 737744.
  • 32
    Subbanagounder G,Leitinger N,Shih PT,Faull KF,Berliner JA. Evidence that phospholipid oxidation products and/or platelet-activating factor play an important role in early atherogenesis: In vitro and In vivo inhibition by WEB 2086. Circ Res 1999; 85: 311318.
  • 33
    Flamand N,Picard S,Lemieux L,Pouliot M,Bourgoin SG,Borgeat P. Effects of pyrrophenone, an inhibitor of group IVA phospholipase A2, on eicosanoid and PAF biosynthesis in human neutrophils. Br J Pharmacol 2006; 149: 385392.
  • 34
    Blank ML,Lee YJ,Cress EA,Snyder F. Stimulation of the de novo pathway for the biosynthesis of platelet-activating factor (PAF) via cytidylyltransferase activation in cells with minimal endogenous PAF production. J Biol Chem 1988; 263: 56565661.
  • 35
    Heller R,Bussolino F,Ghigo D,Garbarino G,Pescarmona G,Till U,Bosia A. Stimulation of platelet-activating factor synthesis in human endothelial cells by activation of the de novo pathway.Phorbol 12-myristate 13-acetate activates 1-alkyl-2-lyso-sn-glycero-3-phosphate: Acetyl-CoA acetyltransferase and dithiothreitol-insensitive 1-alkyl-2-acetyl-sn-glycerol: CDP-choline cholinephosphotransferase. J Biol Chem 1991; 266: 2135821361.
  • 36
    Aguirre C,Jayes FC,Veldhuis JD. Luteinizing hormone (LH) drives diverse intracellular calcium second messenger signals in isolated porcine ovarian thecal cells: Preferential recruitment of intracellular Ca2+ oscillatory cells by higher concentrations of LH. Endocrinology 2000; 141: 22202228.
  • 37
    Davis JS,Tedesco TA,West LA,Maroulis GB,Weakland LL. Effects of human chorionic gonadotropin, prostaglandin F2 alpha and protein kinase C activators on the cyclic AMP and inositol phosphate second messenger systems in cultured human granulosa-luteal cells. Mol Cell Endocrinol 1989; 65: 187193.
  • 38
    Wu YL,Wiltbank MC. Transcriptional regulation of the cyclooxygenase-2 gene changes from protein kinase (PK) A- to PKC-dependence after luteinization of granulosa cells. Biol Reprod 2002; 66: 15051514.
  • 39
    Bridges PJ,Komar CM,Fortune JE. Gonadotropin-induced expression of messenger ribonucleic acid for cyclooxygenase-2 and production of prostaglandins E and F2alpha in bovine preovulatory follicles are regulated by the progesterone receptor. Endocrinology 2006; 147: 47134722.
  • 40
    Smith WL,Garavito RM,Dewitt DL. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 1996; 271: 3315733160.
  • 41
    Grazul-Bilska AT,Navanukraw C,Johnson ML,Arnold DA,Reynolds LP,Redmer DA. Expression of endothelial nitric oxide synthase in the ovine ovary throughout the estrous cycle. Reproduction 2006; 132: 579587.
  • 42
    Ischiropoulos H,Gow A,Thom SR,Kooy NW,Royall JA,Crow JP. Detection of reactive nitrogen species using 2,7-dichlorodihydrofluorescein and dihydrorhodamine 123. Methods Enzymol 1999; 301: 367373.